Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial
NCT ID: NCT01293695
Last Updated: 2016-08-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
187 participants
INTERVENTIONAL
2007-09-30
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breathe for Hot Flashes Randomized Controlled Trial
NCT00819182
Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes
NCT01000623
Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes.
NCT00711529
Hot Water Therapy for the Treatment of Menopause-related Hot Flashes
NCT06192329
Yoga for Treatment of Hot Flashes
NCT00283205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, the treatment effectiveness of hypnosis in reducing physiologically measured (i.e. physiologically measured impact) hot flashes with post-menopausal women has yet to be established relative to a Structured-Attention Control. This is a critical step to further investigate the intervention and to determine if hypnosis reduces the symptoms (i.e. the number of physiological hot flashes) or only the women's perception of symptoms.
Also, the physiologic mechanism by which hypnosis may operate in reducing hot flashes is not known. The present study will compare hypnosis to a Structured-Attention Control in reducing hot flashes (perceived and physiologically monitored) in post-menopausal women in a randomized clinical trial.
Innovations of this study are that it will be the first full scale test of hypnosis for hot flashes; one of the first studies to examine both perceived impact and physiologically measured impact of a mind-body intervention for hot flashes using state-of-the-art 24 hour ambulatory physiological monitoring; the first study to examine the effect of hypnosis for hot flashes on cortisol; and the first investigation of the role of cognitive expectancies in treatment of hot flashes in comparison to a Structured-Attention Control.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hypnosis
Receives 5 weeks of hypnotic relaxation therapy
Hypnosis
Hypnosis relaxation in five weekly sessions
Structured Attention
Meets with therapist for five weekly sessions, but receives no hypnotic relaxation therapy
Structured attention
Meets with therapist for five weekly sessions and receives structured attention/supportive counseling, but receives no hypnotic relaxation therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hypnosis
Hypnosis relaxation in five weekly sessions
Structured attention
Meets with therapist for five weekly sessions and receives structured attention/supportive counseling, but receives no hypnotic relaxation therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. no menstrual period in the past 12 months;
2. no menstrual period in the past 6 months and a medically documented history of FSH level greater than 40; or
3. women who have had a bilateral oophorectomy.
* A self-reported history of a minimum of 7 hot flashes per day or 50 hot flashes per week at baseline.
* Age over 18 years and ability to give her own consent for participation in the study.
* Have discontinued other putative therapies for hot flashes for at least one month prior to enrollment
* Ability to attend weekly sessions.
Exclusion Criteria
* Using any CAM (Complementary and Alternative Medicine) treatments for vasomotor symptoms • Any medical or psychiatric condition that in the opinion of the investigator puts the participant at potential risk during the study.
* Currently using hypnosis for any reason.
* Inability to speak or understand English
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
National Institutes of Health (NIH)
NIH
Baylor University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gary R. Elkins
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary R Elkins, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Baylor University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mind-Body Medicine Research Lab-Baylor University
Waco, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Roberts RL, Rhodes JR, Elkins GR. Effect of Hypnosis on Anxiety: Results from a Randomized Controlled Trial with Women in Postmenopause. J Clin Psychol Med Settings. 2021 Dec;28(4):868-881. doi: 10.1007/s10880-021-09810-3. Epub 2021 Aug 17.
Elkins GR, Fisher WI, Johnson AK. Hypnosis for hot flashes among postmenopausal women study: a study protocol of an ongoing randomized clinical trial. BMC Complement Altern Med. 2011 Oct 11;11:92. doi: 10.1186/1472-6882-11-92.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
194610
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.